Lung Cancer News and Research

Latest Lung Cancer News and Research

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

Lipo-ImmunoTech, LLC, a startup based in Charleston, South Carolina, recently received a Phase I Small Business Technology Transfer grant of just over $224,000 to continue to develop its novel adoptive cell therapy technology for cancer.

2 May 2020

Breakthrough study shows liquid biopsy test can safely detect 26 undiagnosed cancers

Results from a first-of-its-kind study of a multicancer blood test in more than 9,900 women with no evidence or history of cancer showed the liquid biopsy test safely detected 26 undiagnosed cancers, enabling potentially curative treatment.

29 Apr 2020

Differences in reporting methods can over- or under-estimate the safety of drugs

An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.

29 Apr 2020

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

In what is believed to be a first-of-its-kind study to evaluate the safety of a type of immunotherapy before surgery in patients with an aggressive form of skin cancer, researchers report that the treatment eliminated pathologic evidence of cancer in nearly half of the study participants undergoing surgery.

27 Apr 2020

Improvements in air quality and health during COVID-19 lockdown

COVID-19 has devastated lives and communities and will have a horrendous impact on the economy, but it has also revealed some environmental truths that we as humans may not want to hear.

24 Apr 2020

Study: Artificial intelligence strategy can assess and categorize indeterminate pulmonary nodules

Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.

24 Apr 2020

Therapeutic antibody successfully prevents metastases in mice with breast or lung cancer

A receptor in the cell layer that lines the blood vessels from the inside stimulates both the formation of new blood vessels in tumors and metastasis.

24 Apr 2020

New guide released for screening and managing lung cancer during COVID-19

A new expert panel consensus statement published simultaneously today in the journals Radiology: Imaging Cancer, Chest and the Journal of the American College of Radiology provides guidance to clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic.

24 Apr 2020

Combinations of PAC and WFA are highly synergistic against proliferation of non-small cell lung cancer

Oncotarget Volume 11 Issue 16 showed that the sensitivity of H1299 and A549 cells to concomitant treatment with PAC and WFA was greater than that of either PAC or WFA alone.

23 Apr 2020

Series of rare side effects underscores the need to track targeted anti-cancer drugs

Tejas Patil, MD, is a medical oncologist. Lisa Ferrigno, MD, MPH, FACS, is a trauma surgeon. Working with lung cancer patients at University of Colorado Cancer Center, they both, independently, noticed something strange:

23 Apr 2020

Natural mood regulation is impaired in people with depression, research shows

Periods of lockdown during the COVID-19 situation likely to exacerbate problems with mood regulation, say experts at the University of Oxford.

22 Apr 2020

Fast and simple testing may determine the uptake of lung cancer screening

Value in Health, the official journal of ISPOR-;the professional society for health economics and outcomes research, announced today the publication of new research showing that uptake of lung cancer screening may depend on making testing fast and convenient.

22 Apr 2020

Researchers uncover how cancer cells don their invisibility cloaks

Immunotherapy drugs that target a protein called programmed death ligand 1 (PD-L1) on the surface of cancer cells have quickly become a mainstay to treat many forms of cancer, often with dramatic results. But exactly how cancer cells turn on this protein was not completely understood.

22 Apr 2020

Study shows how tumor cells respond to lack of nutrients

Some solid tumors have a very high growth rate, which often leads to a lack of vascularization due to the impossibility to develop, at the same time, the blood vessels that accompany and nourish it.

21 Apr 2020

Report finds nearly half of the U.S. population breathing polluted air

This year marks the 50th anniversary of the Clean Air Act, which is responsible for dramatic improvements in air quality.

21 Apr 2020

Prostate cancer mortality rates predicted to fall in the EU but rise in Poland

Death rates from prostate cancer are predicted to fall in 2020 in the EU, largely due to better diagnosis and treatment, according to new research published in the leading cancer journal Annals of Oncology today (Monday).

20 Apr 2020

Smoking doubles risk of severe COVID-19 disease

The fatality rate among infected people increases among the elderly and those with underlying medical conditions. Now, a new study published as a pre-print on medXriv, links smoking to the progression of COVID-19 disease, suggesting that the odds of disease progression is more than double in smokers.

20 Apr 2020

Death rates from prostate cancer predicted to decline overall in EU

Death rates from prostate cancer are predicted to fall in 2020 in the EU, largely due to better diagnosis and treatment.

17 Apr 2020

Knowledge of cancer diagnosis contributes to longer survival time

In a study of adults in China with lung cancer, patients who knew of their cancer diagnosis generally survived longer than those who did not.

9 Apr 2020

Novel coronavirus targets specific secretory cells in the lungs

Viruses attack specific host cells, which can cause chaos in the body. The novel coronavirus, now called severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 for short, infects respiratory epithelial cells in the lining of the lung, causing difficulty of breathing. The usual cause of death of those who contract the virus is pneumonia and acute respiratory distress syndrome (ARDS). Now, a new study has found that SARS-CoV-2 specifically attack certain progenitor cells called bronchial transient secretory cells in the lungs.

9 Apr 2020

Lung Cancer News and Research

Latest Lung Cancer News and Research

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

Breakthrough study shows liquid biopsy test can safely detect 26 undiagnosed cancers

Differences in reporting methods can over- or under-estimate the safety of drugs

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Improvements in air quality and health during COVID-19 lockdown

Study: Artificial intelligence strategy can assess and categorize indeterminate pulmonary nodules

Therapeutic antibody successfully prevents metastases in mice with breast or lung cancer

New guide released for screening and managing lung cancer during COVID-19

Combinations of PAC and WFA are highly synergistic against proliferation of non-small cell lung cancer

Series of rare side effects underscores the need to track targeted anti-cancer drugs

Natural mood regulation is impaired in people with depression, research shows

Fast and simple testing may determine the uptake of lung cancer screening

Researchers uncover how cancer cells don their invisibility cloaks

Study shows how tumor cells respond to lack of nutrients

Report finds nearly half of the U.S. population breathing polluted air

Prostate cancer mortality rates predicted to fall in the EU but rise in Poland

Smoking doubles risk of severe COVID-19 disease

Death rates from prostate cancer predicted to decline overall in EU

Knowledge of cancer diagnosis contributes to longer survival time

Novel coronavirus targets specific secretory cells in the lungs

Predicting How Contact Tracing Can Control the Spread of COVID-19

Measuring the binding of SARS-CoV-2 Antibodies to the COVID Spike Protein using SPR

Identifying the Starting Points for COVID-19 Treatment

Lung Cancer News and Research

Latest Lung Cancer News and Research

Newsletters you may be interested in